Inflammatory marker | Phase of study | Group | Pre-vaccination or challenge value (standard error) | Highest value for positive APP and lowest value for negative APP (standard error) | Day of detection (post-vaccination or challenge) | Rate of change* |
---|---|---|---|---|---|---|
CRP (μg/mL) | vaccination | 1 | 6.9 (4.5) | 70.6 (11.52) | 24 | 10.23 |
 |  | 2 | 5 (0) | 8.65 (10.66) | 13 | 1.73 |
 | challenge | 1 | 5 (0) | 112 (23.31) | 22 | 22.4 |
 |  | 2 | 5 (0) | 173 (23.31) | 22 | 34.6 |
 |  | 3 | 5 (0) | 252 (23.31) | 14 | 50.4 |
Hp (g/L) | vaccination | 1 | 1.68 (1.62) | 5.04 (0.73) | 24 | 3 |
 |  | 2 | 0.28 (0.23) | 1.88 (0.69) | 24 | 6.7 |
 | challenge | 1 | 1.56 (0.16) | 4.86 (1.21) | 22 | 3.11 |
 |  | 2 | 1.77 (1.17) | 3.78 (1.05) | 22 | 2.13 |
 |  | 3 | 2.13 (0.29) | 8.60 (1.05) | 14 | 4.03 |
SAA (μg/mL) | vaccination | 1 | 5.1 (2.39) | 23.94 (2.9) | 24 | 4.69 |
 |  | 2 | 3.43 (1.92) | 5.1 (2.5) | 13 | 1.48 |
 | challenge | 1 | 1.43 (0.97) | 61 (9.9) | 22 | 42.65 |
 |  | 2 | 2.05 (1.29) | 36 (8.6) | 22 | 17.56 |
 |  | 3 | 1.66 (0.43) | 156.77 (8.6) | 14 | 94.43 |
Albumin (g/dL) | vaccination | 1 | 3.07 (0.06) | 2.33 (0.26) | 31 | 0.75 |
 |  | 2 | 3 (0.31) | 3.01 (0.29) | 31 | 1 |
 | challenge | 1 | 3.64 (0.4) | 2.8 (0.15) | 22 | 0.76 |
 |  | 2 | 3.99 (0.24) | 2.8 (0.15) | 22 | 0.7 |
 |  | 3 | 3.79 (0.19) | 1.64 (0.17) | 22 | 0.43 |
TAC (mmol/L) | vaccination | 1 | 0.36 (0.16) | 0.07 (0.06) | 31 | 0.19 |
 |  | 2 | 0.45 (0.017) | 0.04 (0.06) | 39 | 0.08 |
 | challenge | 1 | 0.36 (0.06) | 0.12 (0.08) | 22 | 0.33 |
 |  | 2 | 0.46 (0.1) | 0.2 (0.06) | 14 | 0.43 |
 |  | 3 | 0.24 (0.13) | 0.08 (0.03) | 14 | 0.33 |
PON-1 (IU/mL) | vaccination | 1 | 2.91 (0.27) | 2.1 (0.16) | 31 | 0.72 |
 |  | 2 | 2.43 (0.29) | 2.2 (0.16) | 38 | 0.9 |
 | challenge | 1 | 3.64 (0.6) | 2.1 (0.23) | 22 | 0.57 |
 |  | 2 | 3.9 (0.68) | 2.05 (0.23) | 22 | 0.52 |
 |  | 3 | 3.62 (0.11) | 1.3 (0.23) | 22 | 0.35 |